Healthcare - Biotechnology - NASDAQ - US
$ 87.83
-7.63 %
$ 4.75 B
Market Cap
-123.7
P/E
INCOME STATEMENT
110 M
REVENUE
-89.9 M
OPERATING INCOME
-70.7 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Arcellx, Inc.
| Revenue | 110 M |
| Cost Of Revenue | 2.04 M |
| Gross Profit | 108 M |
| Operating Expenses | 200 M |
| Operating Income | -89.9 M |
| Other Expenses | -19.2 M |
| Net Income | -70.7 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 110.3 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 2.0 | 2.2 | 1.0 | 0.6 | 0.3 | 0 |
| Gross Profit | 108.3 | (2.2) | (1.0) | (0.6) | (0.3) | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 200.2 | 191.3 | 65.0 | 32.1 | 18.0 | 8.3 |
| Selling, General and Administrative Expenses | 66.3 | 41.7 | 18.1 | 7.0 | 2.2 | 2.2 |
| Research and Development Expenses | 133.8 | 149.6 | 46.9 | 25.1 | 15.8 | 6.1 |
| Operating Income | (89.9) | (191.3) | (65.0) | (32.1) | (18.0) | (8.3) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 3.8 | 1.7 | 10 K | 0 | 0 | 0 |
| Total Other Income | 19.9 | 2.6 | 49 K | 1 K | 2 K | 999 |
| Pre-Tax Income | (70.0) | (188.7) | (65.0) | (32.1) | (18.0) | (8.3) |
| NET INCOME | ||||||
| Tax Provision | 0.7 | (2.6) | (1.0) | 0.4 | 0.2 | 0 |
| Net Income | (70.7) | (186.1) | (63.9) | (32.1) | (18.0) | (8.3) |
| EPS | 1.47 | 4.22 | 1.79 | 0.96 | 0.52 | 50.2 |